DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dabrowiak, J. C.
Right arrow Articles by Souid, A.-K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dabrowiak, J. C.
Right arrow Articles by Souid, A.-K.

Vol. 30, Issue 12, 1378-1384, December 2002

Kinetic Study of the Reaction of Cisplatin with Thiols

James C. Dabrowiak, Jerry Goodisman, and Abdul-Kader Souid

Department of Chemistry, Syracuse University, Syracuse, New York (J.C.D., J.G.); and Department of Pediatrics, Upstate Medical University, State University of New York, Syracuse, New York (A.-K.S.)

The reactions of cisplatin [cis-diamminedichloroplatinum(II), CDDP] with glutathione (GSH) and drug thiols were investigated at 37°C in 100 mM Tris-NO3, pH ~7.4, using a clinically relevant concentration of CDDP (33 µM), a large excess of GSH (16.5 mM), and [NaCl] of 4.62 mM. The conditions were designed to mimic passage of CDDP through the cytosol. The reactions were studied by UV-absorption spectroscopy, high-pressure liquid chromatography (HPLC), and atomic absorption spectroscopy. The initial rates, detected by UV absorbance, confirmed that the reactions are first order in [CDDP]. The HPLC peak corresponding to CDDP was analyzed for platinum content by atomic absorption spectroscopy, which decreased exponentially with time, confirming that the reactions are first order in [CDDP] and allowing determination of the pseudo first order rate constants (k1). For reaction of the dichloro form of CDDP with GSH, the k1 value was ~2.2 × 10-4 s-1 (t1/2 of ~53 min), giving the second order rate constant value (k2) of ~1.3 × 10-2 M-1 s-1. Reaction of a mixture of the aquated forms of CDDP with GSH gave a lower k1 value (~0.9 × 10-4 s-1). Reaction of CDDP with sodium 2-mercaptoethanesulfonate (mesna) gave a k1 value of ~1.8 × 10-4 s-1 (t1/2 of ~65 min and k2 of ~1.1 × 10-2 M-1 s-1). Reaction of CDDP with S-2-(3-aminopropylamino)ethanethiol (WR-1065) gave a k1 value of ~12.0 × 10-4 s-1 (t1/2 of ~10 min and k2 of ~7.3 × 10-2 M-1 s-1). The relatively slow reaction rate of CDDP with GSH is consistent with the efficient DNA platination by CDDP in the presence of millimolar concentration of GSH in the cytosol.


Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
N. Ragunathan, J. Dairou, B. Pluvinage, M. Martins, E. Petit, N. Janel, J.-M. Dupret, and F. Rodrigues-Lima
Identification of the Xenobiotic-Metabolizing Enzyme Arylamine N-Acetyltransferase 1 as a New Target of Cisplatin in Breast Cancer Cells: Molecular and Cellular Mechanisms of Inhibition
Mol. Pharmacol., June 1, 2008; 73(6): 1761 - 1768.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
P. Videhult, G. Laurell, I. Wallin, and H. Ehrsson
Kinetics of Cisplatin and its monohydrated complex with sulfur-containing compounds designed for local otoprotective administration.
Experimental Biology and Medicine, November 1, 2006; 231(10): 1638 - 1645.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. B. Hasinoff, X. Wu, O. V. Krokhin, W. Ens, K. G. Standing, J. L. Nitiss, T. Sivaram, A. Giorgianni, S. Yang, Y. Jiang, et al.
Biochemical and Proteomics Approaches to Characterize Topoisomerase II{alpha} Cysteines and DNA as Targets Responsible for Cisplatin-Induced Inhibition of Topoisomerase II{alpha}
Mol. Pharmacol., March 1, 2005; 67(3): 937 - 947.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. Hagrman, J. Goodisman, and A.-K. Souid
Kinetic Study on the Reactions of Platinum Drugs with Glutathione
J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 658 - 666.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
D. Hagrman, J. Goodisman, J. C. Dabrowiak, and A.-K. Souid
KINETIC STUDY ON THE REACTION OF CISPLATIN WITH METALLOTHIONEIN
Drug Metab. Dispos., July 1, 2003; 31(7): 916 - 923.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.